These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

901 related articles for article (PubMed ID: 9165306)

  • 1. Oxidative stress hypothesis in Alzheimer's disease.
    Markesbery WR
    Free Radic Biol Med; 1997; 23(1):134-47. PubMed ID: 9165306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metals, oxidative stress and neurodegenerative disorders.
    Jomova K; Vondrakova D; Lawson M; Valko M
    Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.
    Butterfield DA; Castegna A; Lauderback CM; Drake J
    Neurobiol Aging; 2002; 23(5):655-64. PubMed ID: 12392766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
    Butterfield DA
    Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations on oxidative stress and therapeutical implications in dementia.
    Durany N; Münch G; Michel T; Riederer P
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 3():68-73. PubMed ID: 10654103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative alterations in Alzheimer's disease.
    Markesbery WR; Carney JM
    Brain Pathol; 1999 Jan; 9(1):133-46. PubMed ID: 9989456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress.
    Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA
    Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
    Smith DG; Cappai R; Barnham KJ
    Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease.
    Calingasan NY; Uchida K; Gibson GE
    J Neurochem; 1999 Feb; 72(2):751-6. PubMed ID: 9930749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress.
    Butterfield DA; Lauderback CM
    Free Radic Biol Med; 2002 Jun; 32(11):1050-60. PubMed ID: 12031889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.
    Prasad K
    Mol Cell Biochem; 2019 Sep; 459(1-2):95-112. PubMed ID: 31079281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress in Alzheimer's disease.
    Smith MA; Rottkamp CA; Nunomura A; Raina AK; Perry G
    Biochim Biophys Acta; 2000 Jul; 1502(1):139-44. PubMed ID: 10899439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease.
    Smith MA; Nunomura A; Zhu X; Takeda A; Perry G
    Antioxid Redox Signal; 2000; 2(3):413-20. PubMed ID: 11229355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide.
    Butterfield DA; Drake J; Pocernich C; Castegna A
    Trends Mol Med; 2001 Dec; 7(12):548-54. PubMed ID: 11733217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Alzheimer's disease a mitochondrial disorder?
    Cash AD; Perry G; Ogawa O; Raina AK; Zhu X; Smith MA
    Neuroscientist; 2002 Oct; 8(5):489-96. PubMed ID: 12374431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.
    Sayre LM; Zelasko DA; Harris PL; Perry G; Salomon RG; Smith MA
    J Neurochem; 1997 May; 68(5):2092-7. PubMed ID: 9109537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and Alzheimer disease.
    Christen Y
    Am J Clin Nutr; 2000 Feb; 71(2):621S-629S. PubMed ID: 10681270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease.
    Matsuoka Y; Picciano M; La Francois J; Duff K
    Neuroscience; 2001; 104(3):609-13. PubMed ID: 11440793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
    Tamaoka A
    Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
    Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
    Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.